Mesenchymal Chondrosarcoma in Children and Young Adults: A Single Institution Retrospective Review
Sarcoma · 2015 · 2015 · 1-6
DOI: 10.1155/2015/608279 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sarcoma, 2015. Verfasst von Michael W Bishop und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA ; Department of Pediatrics, University …. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NCI NIH HHS, NCATS NIH HHS, American Lebanese Syrian Associated Charities.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Mesenchymal chondrosarcoma is an aggressive, uncommon histologic entity arising in bone and soft tissues. We reviewed our institutional experience with this rare diagnosis.
Methods
We conducted a retrospective chart review on patients with mesenchymal chondrosarcoma over a 24-year period. Clinicopathologic and radiographic features were reviewed.
Results
Twelve patients were identified. Nine were females; median age was 14.5 years (1.2–19.7 years). The most common site was the head/neck (7/12). Disease was localized in 11/12 patients (one with lung nodules). Six with available tissue demonstrated NCOA2 rearrangement by FISH. Six underwent upfront surgical resection, and six received neoadjuvant therapy (2 chemotherapy alone and 4 chemotherapy and radiation). All patients received adjuvant chemotherapy (most commonly ifosfamide/doxorubicin) and/or radiation (median dose 59.4 Gy). At a median follow-up of 4.8 years, 5-year disease-free survival and overall survival were 68.2% (95% CI 39.8%, 96.6%) and 88.9% (95% CI 66.9%, 100%). Two patients had distant recurrences at 15 and 42 months, respectively.
Conclusion
Aggressive surgical resection of mesenchymal chondrosarcoma with chemoradiotherapy yields excellent local control and may reduce likelihood of late recurrence. Characterization of downstream targets of the HEY1-NCOA2 fusion protein, xenograft models, and drug screening are needed to identify novel therapeutic strategies.
Autor:innen und Institutionen
- Department of Oncology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA ; Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN 38105, USA.
- Department of Otolaryngology, University of Tennessee Health Science Center, Memphis, TN 38105, USA.
- Department of Pathology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA.
- Department of Oncology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA ; Department of Radiological Sciences, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis…
- Department of Surgery, University of Tennessee Health Science Center, Memphis, TN 38105, USA.
- Department of Biostatistics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA.
Förderung
- NCI NIH HHS
- NCATS NIH HHS
- American Lebanese Syrian Associated Charities
Zitieren
APA
Bishop, M. W., Somerville, J. M., Bahrami, A., Kaste, S. C., Interiano, R. B., Wu, J., Mao, S., Boop, F. A., Williams, R. F., Pappo, A. S., & Samant, S. (2015). Mesenchymal Chondrosarcoma in Children and Young Adults: A Single Institution Retrospective Review. Sarcoma, 2015, 1-6. https://doi.org/10.1155/2015/608279
Vancouver
Bishop MW, Somerville JM, Bahrami A, Kaste SC, Interiano RB, Wu J, et al. Mesenchymal Chondrosarcoma in Children and Young Adults: A Single Institution Retrospective Review. Sarcoma. 2015;2015:1-6. doi:10.1155/2015/608279
BibTeX
@article{Bishop2015,
author = {Bishop, Michael W and Somerville, Jessica M and Bahrami, Armita and Kaste, Sue C and Interiano, Rodrigo B and Wu, Jianrong and Mao, Shenghua and Boop, Frederick A and Williams, Regan F and Pappo, Alberto S and Samant, Sandeep},
title = {Mesenchymal Chondrosarcoma in Children and Young Adults: A Single Institution Retrospective Review},
journal = {Sarcoma},
year = {2015},
volume = {2015},
pages = {1--6},
doi = {10.1155/2015/608279}
}
EUVIMED